AZENTA INC (AZTA) Fundamental Analysis & Valuation

NASDAQ:AZTA • US1143401024

Current stock price

20.45 USD
+0.26 (+1.29%)
At close:
20.45 USD
0 (0%)
After Hours:

This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AZTA Profitability Analysis

1.1 Basic Checks

  • In the past year AZTA was profitable.
  • AZTA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AZTA reported negative net income in multiple years.
  • AZTA had a positive operating cash flow in 4 of the past 5 years.
AZTA Yearly Net Income VS EBIT VS OCF VS FCFAZTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of AZTA (-2.79%) is comparable to the rest of the industry.
  • AZTA has a Return On Equity of -3.37%. This is in the better half of the industry: AZTA outperforms 60.71% of its industry peers.
Industry RankSector Rank
ROA -2.79%
ROE -3.37%
ROIC N/A
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
AZTA Yearly ROA, ROE, ROICAZTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • Looking at the Gross Margin, with a value of 44.59%, AZTA is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • AZTA's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
AZTA Yearly Profit, Operating, Gross MarginsAZTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

8

2. AZTA Health Analysis

2.1 Basic Checks

  • AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AZTA has more shares outstanding
  • AZTA has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AZTA has an improved debt to assets ratio.
AZTA Yearly Shares OutstandingAZTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AZTA Yearly Total Debt VS Total AssetsAZTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 3.06 indicates that AZTA is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of AZTA (3.06) is better than 66.07% of its industry peers.
  • There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.06
ROIC/WACCN/A
WACC10.93%
AZTA Yearly LT Debt VS Equity VS FCFAZTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • AZTA has a Current Ratio of 2.92. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AZTA (2.92) is comparable to the rest of the industry.
  • AZTA has a Quick Ratio of 2.61. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of AZTA (2.61) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.61
AZTA Yearly Current Assets VS Current LiabilitesAZTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

5

3. AZTA Growth Analysis

3.1 Past

  • AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.89%, which is quite good.
  • Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
  • Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
  • Measured over the past years, AZTA shows a quite strong growth in Revenue. The Revenue has been growing by 8.86% on average per year.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%

3.2 Future

  • Based on estimates for the next years, AZTA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.49% on average per year.
  • AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y51.54%
EPS Next 2Y41.77%
EPS Next 3Y34.58%
EPS Next 5Y27.49%
Revenue Next Year4.92%
Revenue Next 2Y5.29%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AZTA Yearly Revenue VS EstimatesAZTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
AZTA Yearly EPS VS EstimatesAZTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

5

4. AZTA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 37.87, the valuation of AZTA can be described as expensive.
  • Based on the Price/Earnings ratio, AZTA is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
  • AZTA's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.54.
  • The Price/Forward Earnings ratio is 19.20, which indicates a rather expensive current valuation of AZTA.
  • 80.36% of the companies in the same industry are more expensive than AZTA, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.70. AZTA is around the same levels.
Industry RankSector Rank
PE 37.87
Fwd PE 19.2
AZTA Price Earnings VS Forward Price EarningsAZTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • AZTA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AZTA is cheaper than 92.86% of the companies in the same industry.
  • AZTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 69.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.45
EV/EBITDA 11.21
AZTA Per share dataAZTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AZTA's earnings are expected to grow with 34.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y41.77%
EPS Next 3Y34.58%

0

5. AZTA Dividend Analysis

5.1 Amount

  • AZTA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AZTA Fundamentals: All Metrics, Ratios and Statistics

AZENTA INC

NASDAQ:AZTA (3/23/2026, 8:00:01 PM)

After market: 20.45 0 (0%)

20.45

+0.26 (+1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners115.54%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap941.93M
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target38.47 (88.12%)
Short Float %10.24%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-4.35%
PT rev (3m)-2.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.75%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 37.87
Fwd PE 19.2
P/S 1.58
P/FCF 30.45
P/OCF 15.1
P/B 0.55
P/tB 1.03
EV/EBITDA 11.21
EPS(TTM)0.54
EY2.64%
EPS(NY)1.07
Fwd EY5.21%
FCF(TTM)0.67
FCFY3.28%
OCF(TTM)1.35
OCFY6.62%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.73
PEG (5Y)N/A
Graham Number21.27
Profitability
Industry RankSector Rank
ROA -2.79%
ROE -3.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.59%
FCFM 5.2%
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 55.45%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion 156.34%
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.61
Altman-Z 3.06
F-Score5
WACC10.93%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y51.54%
EPS Next 2Y41.77%
EPS Next 3Y34.58%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year4.92%
Revenue Next 2Y5.29%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year495.06%
EBIT Next 3Y107.17%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%

AZENTA INC / AZTA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AZENTA INC?

ChartMill assigns a fundamental rating of 5 / 10 to AZTA.


What is the valuation status of AZENTA INC (AZTA) stock?

ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.


How profitable is AZENTA INC (AZTA) stock?

AZENTA INC (AZTA) has a profitability rating of 3 / 10.


Can you provide the financial health for AZTA stock?

The financial health rating of AZENTA INC (AZTA) is 8 / 10.


How sustainable is the dividend of AZENTA INC (AZTA) stock?

The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.